• Small Molecules
      • Discovery
        Development
        Manufacturing
    • Biologics
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers

Syngene purchases land to expand operations in Genome Valley, Hyderabad

Read Press Release
Read Press Release

How Syngene supported a biotech in developing a PROTAC molecule for treating cancer

Read Case Study
Read Case Study

Cracking the Code

Transformative role of pDNA in Cell and Gene therapy

Read White Paper
Read White Paper

Research that changes the world for the better

We are accelerating drug innovation and development for companies globally

Explore Syngene
Explore Syngene

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

More
More

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

More
More

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

More
More

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

More
More

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

More
More

InstaVisit – Visit Syngene virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

View Now
View Now
Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities
0 +

Active Clients

0

Collaborations with top 20 Pharma/Biotech companies

5200 +

Scientists

0

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents 

Latest News

View all
View all

Syngene purchases land to expand operations in Genome Valley, Hyderabad

More
Press Release
14th Sep, 2023

Q1 FY24 revenue up 26%, PAT up 26%

More
Press Release
25th Jul, 2023

Power of AI to identify better drug targets and drug candidates

More
News
21st Jul, 2023

Insights

View all
View all

Leveraging High-Throughput Screening services to accelerate Drug Discovery and Development

The many applications of HTS and how it has evolved beyond lead identification and candidate optimization today.
More

Harnessing the power of induced proximity-based drugs and precision medicine for treating cancer

How Syngene is supporting clients in treating cancer using targeted protein degradation, protein stabilization approaches, and precision medicine therapies.
More
PROTAC-blog

Five questions that determine the success of your PROTAC programs

Challenges in developing PROTACs and critical questions that need to be addressed to move PROTAC molecules from Target to IND successfully.
More

Upcoming events

View all
View all

13th Drug Discovery Strategic Summit (DDSS)

5th & 6th Oct
Amsterdam

Festival of Biologics Europe

10th to 12th Oct
Basel

Bio Japan 2023

11th to 13th Oct
Yokohama

World Vaccine Congress Europe

17th to 19th Oct
Barcelona

AAPS PharmSci 2023

22nd to 25th October
Orlando,USA

CPHI Barcelona

24th to 26th October
Barcelona, Spain
Book a meeting

Corporate Social Responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.
More
More

Syngene International Ltd

+1.35(0.32%)+1.35(0.32%)

Governance

Behind consistent growth is good governance

More
More

Careers

Discover a world of opportunities

More
More

Annual Reports

Touching a billon lives through innnovation

More
More

Sign-up for our newsletter

© 2023. Syngene International Limited

Linkedin-in Youtube Facebook-f

Quick links

Business

Get in touch

Other links
Linkedin-in Youtube Facebook-f

© 2023. Syngene International Limited

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

Close

To view or email, Please share your details view

To download, Please share your details